Description of Collaborative Activity: |
In accordance with the Combating Autism Act of 2006 (CAA) and the Combating Autism Reauthorization Act of 2011 (CARA), the Interagency Autism Coordinating Committee (IACC), a federal advisory committee, is charged with coordinating all efforts with the Department of Health and Human Services concerning autism spectrum disorder (ASD). The committee was established in an effort to accelerate progress in autism spectrum disorder (ASD) biomedical and services research by improving coordination and communication across the Federal government and by working in partnership with the autism community. The committee is composed of officials from many different federal agencies involved in autism research and services, as well as members with ASD, parents, advocates, researchers and other members of the autism community. Member agencies include NIH, CDC, FDA, CMS, ACL, ACF and HRSA within HHS, Department of Education and Department of Defense. In accordance with the CAA and CARA, the committee is charged with providing advice to the Secretary of Health and Human Services regarding activities and issues related to ASD. The IACC is also tasked with developing and annually updating a strategic plan for ASD research, monitoring federal activities related to autism, and preparing an annual summary of advances in ASD research. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
NIH Participating Institutes/Centers/Office of the Director: |
NICHD, NIDCD, NIEHS, NIMH, NINDS |
HHS Agency Collaborators on this Activity: |
ACF, ACL, CDC, CMS, FDA, HRSA, SAMHSA |
